ECSP993181A - PROCEDURE FOR THE PREPARATION OF A HIGH PURITY COMPOSITION OF (7ALFA, 17ALFA) - 17 - HIDROXI-7-19-NOR-17- PREGN-5 (10) -EN -20-IN-3-ONA - Google Patents

PROCEDURE FOR THE PREPARATION OF A HIGH PURITY COMPOSITION OF (7ALFA, 17ALFA) - 17 - HIDROXI-7-19-NOR-17- PREGN-5 (10) -EN -20-IN-3-ONA

Info

Publication number
ECSP993181A
ECSP993181A ECSP993181A ECSP993181A EC SP993181 A ECSP993181 A EC SP993181A EC SP993181 A ECSP993181 A EC SP993181A EC SP993181 A ECSP993181 A EC SP993181A
Authority
EC
Ecuador
Prior art keywords
preparation
high purity
7alfa
17alfa
hidroxi
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Peter Huub Gerard Maria Kirchholtes
Gerard Arnoud Jozef Maria Tereza Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993181 priority Critical patent/ECSP993181A/en
Publication of ECSP993181A publication Critical patent/ECSP993181A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a un procedimiento para la preparación de una composición de alta pureza de (7,17)-17-hidroxi.7-metil-19-nor-17-oregn-4-en-20-in-3-ona. Esta composición puede ser usada como una fuente para la preparación de unidades de dosificación farmacéuticas estables.The invention relates to a process for the preparation of a high purity composition of (7,17) -17-hydroxy.7-methyl-19-nor-17-oregn-4-en-20-in-3-one . This composition can be used as a source for the preparation of stable pharmaceutical dosage units.

ECSP993181 1999-10-15 1999-10-15 PROCEDURE FOR THE PREPARATION OF A HIGH PURITY COMPOSITION OF (7ALFA, 17ALFA) - 17 - HIDROXI-7-19-NOR-17- PREGN-5 (10) -EN -20-IN-3-ONA ECSP993181A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993181 ECSP993181A (en) 1999-10-15 1999-10-15 PROCEDURE FOR THE PREPARATION OF A HIGH PURITY COMPOSITION OF (7ALFA, 17ALFA) - 17 - HIDROXI-7-19-NOR-17- PREGN-5 (10) -EN -20-IN-3-ONA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993181 ECSP993181A (en) 1999-10-15 1999-10-15 PROCEDURE FOR THE PREPARATION OF A HIGH PURITY COMPOSITION OF (7ALFA, 17ALFA) - 17 - HIDROXI-7-19-NOR-17- PREGN-5 (10) -EN -20-IN-3-ONA

Publications (1)

Publication Number Publication Date
ECSP993181A true ECSP993181A (en) 1999-12-23

Family

ID=42044170

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993181 ECSP993181A (en) 1999-10-15 1999-10-15 PROCEDURE FOR THE PREPARATION OF A HIGH PURITY COMPOSITION OF (7ALFA, 17ALFA) - 17 - HIDROXI-7-19-NOR-17- PREGN-5 (10) -EN -20-IN-3-ONA

Country Status (1)

Country Link
EC (1) ECSP993181A (en)

Similar Documents

Publication Publication Date Title
SE9904505D0 (en) Novel compounds
CL2009001682A1 (en) Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00).
BR0007781A (en) Physiologically active conjugate, composition, and, process for the production of a peg-gcsf conjugate
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
EE02962B1 (en) Mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
SE0102055D0 (en) New Compounds
SE0102440D0 (en) New compound
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
EP1019047A4 (en) Antithrombotic agents
BR0114395A (en) Pharmaceutical composition for oral supply administration
IL163608A (en) Amino/imino-substituted sulfonanilides and derivatives thereof, process for the preparation thereof, pharmaceutical compositions and antibody conjugates comprising them and use thereof in the preparation of medicaments for treating proliferative disorders
AR024411A1 (en) POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO [2.2.2] OCT-3-ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS.
ES2192789T3 (en) HYDRAZON-BENZAZULEN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS.
EP1027051A4 (en) Antithrombotic agents
SE0000303D0 (en) Novel compounds
YU87501A (en) Pharmaceutical complex
YU48200A (en) Pharmaceutical compositions
SE9902742D0 (en) New pharmaceutical formultion